The diversity of TNBC, the lack of hormonal receptors, and less effective targeted therapy greatly increase the chance for early relapse, increase metastatic potential, and diminish overall survival in comparison to other breast cancer subtypes [3]. The gene discussed is NR4A1; the disease is breast carcinoma.